103 research outputs found
Composition Modulation over Three-Way Catalysts
Compared to conventional internal combustion engines, modern hybrid electric vehicles (HEVs) can save fuel under urban driving conditions, which results in lower CO2 emissions. However, frequent stops and restart of the HEV engine go along with periods of low exhaust gas temperatures and therefore cause a decline in pollutant conversion over the three-way catalyst (TWC) system that is typically used for exhaust gas after-treatment [1]. Composition modulation is reported to increase pollutant conversion over the TWC at low temperatures and to be beneficial for cold start performance [2]. In this regard, dithering frequency, amplitude, temperature, and space velocity are the most important parameters influencing the rate enhancement from composition modulation. A synthetic gas bench with fast switching valves is used to conduct a comprehensive parameter study on the influence of dithering parameters on the TWC performance. For this, monolithic catalysts with Pd/Al2O3 and a commercially relevant Ce-based Pd catalyst are prepared by incipient wetness impregnation and subsequent dip coating. The application of a square wave signal to the catalytic converter remains a challenging task due to axial dispersion in the setup periphery. To further examine the phenomena and predict the behaviour of the TWC under periodic conditions, a detailed kinetic model is under development. Literature suggests that the dithering effect can be described by kinetic models with detailed chemistry considering the interaction among species adsorbed on surface sites [3]. Under the assumption of an ideally backmixed reactor, initial modelling results exploiting a detailed microkinetic model for CO oxidation [4] show an increased average CO conversion for all frequencies around the light-off and a decrease for higher temperature (Figure 1). Furthermore, an increase of optimal frequency with increasing temperature and amplitude was observed for constant amplitude and temperature respectively, which is in line with experimental data from literature [2]. Using transient data for model development will provide valuable insights on surface phenomena that are responsible for the dithering effect on three-way catalysts and will ultimately allow for reducing pollutant emissions from HEVs.
[1] Y. Huang, N. Surawski, B. Organ, J. Zhou, O. Tang and E. Chan, "Fuel consumption and emission performance under real driving: Comparison between hybrid and conventional vehicles", Sci. Total Environ. 659, 275-282 (2019).
[2] P. Silveston, "Automotive exhaust catalysis: Is periodic operation beneficial?", Chem. Eng. Sci. 51, 2419-2426 (1996).
[3] P. KoÄŤĂ, M. KubĂÄŤek, M. Marek, "Multifunctional aspects of Three-Way Catalyst: Effects of Complex Washcoat Composition", Chem. Eng. Res. Des. 82, 284-292 (2004).
[4] D. Chan, S. Tischer, J. Heck, C. Diehm, O. Deutschmann, "Correlation between catalytic activity and catalytic surface area of a Pt/Al2O3 DOC: An experimental and microkinetic modelling study", Appl. Catal. B 156-157, 153-165 (2014)
Replication of cowpox virus in macrophages is dependent on the host range factor p28/N1R
Zoonotic orthopoxvirus infections continue to represent a threat to human health. The disease caused by distinct orthopoxviruses differs in terms of symptoms and severity, which may be explained by the unique repertoire of virus factors that modulate the host’s immune response and cellular machinery. We report here on the construction of recombinant cowpox viruses (CPXV) which either lack the host range factor p28 completely or express truncated variants of p28. We show that p28 is essential for CPXV replication in macrophages of human or mouse origin and that the C-terminal RING finger domain of p28 is necessary to allow CPXV replication in macrophages.Peer Reviewe
Generation of Leukaemia-Derived Dendritic Cells (DCleu) to improve anti-leukaemic activity in AML: selection of the most efficient response modifier combinations
Dendritic cells (DC) and leukaemia derived DC (DC(leu)) are potent stimulators of anti-leukaemic activity in acute myeloid leukaemia (AML) and can be generated from mononuclear cells in vitro following standard DC/DC(leu)-generating protocols. With respect to future clinical applications though, DC/DC(leu)-generating protocols specifically designed for application in a whole-blood-(WB)-environment must be established. Therefore, we developed ten new DC/DC(leu)-generating protocols (kits; Kit-A/-C/-D/-E/-F/-G/-H/-I/-K/-M) for the generation of DC/DC(leu) from leukaemic WB, containing calcium-ionophore, granulocyte-macrophage-colony-stimulating-factor (GM-CSF), tumour-necrosis-factor-alpha, prostaglandin-E(1) (PGE(1)), prostaglandin-E(2) (PGE(2)) and/or picibanil (OK-432). All protocols were evaluated regarding their performance in generating DC/DC(leu) using refined classification and/or ranking systems; DC/DC(leu) were evaluated regarding their performance in stimulating anti-leukaemic activity using a cytotoxicity fluorolysis assay. Overall, we found the new kits capable to generate (mature) DC/DC(leu) from leukaemic WB. Through refined classification and ranking systems, we were able to select Kit-I (GM-CSF + OK-432), -K (GM-CSF + PGE(2)) and -M (GM-CSF + PGE(1)) as the most efficient kits in generating (mature) DC/DC(leu), which are further competent to stimulate immunoreactive cells to show an improved anti-leukaemic cytotoxicity as well. This great performance of Kit-I, -K and -M in mediating DC/DC(leu)-based anti-leukaemic immunity in a WB-environment in vitro constitutes an important and directive step for translating DC/DC(leu)-based immunotherapy of AML into clinical application
The search for the ideal biocatalyst
While the use of enzymes as biocatalysts to assist in the industrial manufacture of fine chemicals and pharmaceuticals has enormous potential, application is frequently limited by evolution-led catalyst traits. The advent of designer biocatalysts, produced by informed selection and mutation through recombinant DNA technology, enables production of process-compatible enzymes. However, to fully realize the potential of designer enzymes in industrial applications, it will be necessary to tailor catalyst properties so that they are optimal not only for a given reaction but also in the context of the industrial process in which the enzyme is applied
- …